{"id":"NCT01564784","sponsor":"Pfizer","briefTitle":"A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia","officialTitle":"AN OPEN-LABEL, RANDOMIZED PHASE 3 STUDY OF INOTUZUMAB OZOGAMICIN COMPARED TO A DEFINED INVESTIGATOR'S CHOICE IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY CD22-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-08-02","primaryCompletion":"2016-03-08","completion":"2017-01-04","firstPosted":"2012-03-28","resultsPosted":"2018-01-17","lastUpdate":"2019-01-09"},"enrollment":326,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Acute Lymphoblastic Leukemia"],"interventions":[{"type":"DRUG","name":"inotuzumab ozogamicin","otherNames":[]},{"type":"DRUG","name":"FLAG (fludarabine, cytarabine and G-CSF)","otherNames":[]},{"type":"DRUG","name":"HIDAC (high dose cytarabine)","otherNames":[]},{"type":"DRUG","name":"cytarabine and mitoxantrone","otherNames":[]}],"arms":[{"label":"Arm A","type":"EXPERIMENTAL"},{"label":"Arm B","type":"ACTIVE_COMPARATOR"}],"summary":"This study will compare the efficacy, in terms of complete responses and overall survival, of inotuzumab ozogamicin versus investigator's choice of chemotherapy.","primaryOutcome":{"measure":"Percentage of Participants With Hematologic Remission (Complete Remission [CR]/Complete Remission With Incomplete Hematologic Recovery [CRi]) as Assessed by the Endpoint Adjudication Committee (EAC)","timeFrame":"Screening, Day 16 to 28 of Cycles 1, 2 and 3, then every 1 to 2 cycles (or as clinically indicated) up to approximately 4 weeks (end of treatment [EoT]) from the last dose","effectByArm":[{"arm":"Inotuzumab Ozogamicin","deltaMin":80.7,"sd":null},{"arm":"Defined Investigator's Choice of Chemotherapy","deltaMin":29.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":198,"countries":["United States","Argentina","Australia","Canada","China","Czechia","Finland","France","Germany","Hungary","Italy","Japan","Netherlands","Poland","Singapore","South Korea","Spain","Sweden","Taiwan","United Kingdom"]},"refs":{"pmids":["38607410","35643855","35622074","33602684","33231879","32769965","31790983","31655984","30920645","29381191","29330398","28687420","27292104"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":85,"n":164},"commonTop":["Thrombocytopenia","Neutropenia","Anaemia","Nausea","Pyrexia"]}}